Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX).
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Pediatrix Medical Group (MD)
Mizuho Securities analyst Ann Hynes maintained a Hold rating on Pediatrix Medical Group today and set a price target of $27.00. The company’s shares closed last Monday at $26.38.
According to TipRanks.com, Hynes is a 5-star analyst with an average return of
Pediatrix Medical Group has an analyst consensus of Moderate Buy, with a price target consensus of $24.80, which is a -5.6% downside from current levels. In a report issued on July 4, TipRanks – Anthropic also reiterated a Hold rating on the stock with a $29.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Travere Therapeutics (TVTX)
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Travere Therapeutics, with a price target of $61.00. The company’s shares closed last Monday at $54.64.
According to TipRanks.com, Chico is a 5-star analyst with an average return of
Currently, the analyst consensus on Travere Therapeutics is a Strong Buy with an average price target of $58.33, which is a 3.1% upside from current levels. In a report issued on July 7, Canaccord Genuity also maintained a Buy rating on the stock with a $56.00 price target.
Read More on MD:
